Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew N Stephens

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2017
Autoantibodies against HSF1 and CCDC155 as Biomarkers of Early-Stage, High-Grade Serous Ovarian CancerAmy L Wilson, Laura R Moffitt, Nadine Duffield, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 2, 2021
Chemoresistance is mediated by ovarian cancer leader cells in vitroNazanin Karimnia, Amy L Wilson, Emma Green, et al.
Journal of Proteome Research|September 22, 2009
Proteomic identification of caldesmon as a physiological substrate of proprotein convertase 6 in human uterine decidual cells essential for pregnancy establishmentLynette M Kilpatrick, Andrew N Stephens, Belinda M Hardman, et al.
Frontiers in Oncology|October 26, 2020
Ovarian Blood Sampling Identifies Junction Plakoglobin as a Novel Biomarker of Early Ovarian CancerFlorian Weiland, Noor A Lokman, Manuela Klingler-Hoffmann, et al.
Cancers|August 27, 2021
Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This MalignancyRhiane Moody, Kirsty Wilson, Nirmala Chandralega Kampan, et al.
Plos One|August 4, 2012
Proteomic changes in rat spermatogenesis in response to in vivo androgen manipulation; impact on meiotic cellsPeter G Stanton, Pavel Sluka, Caroline F H Foo, et al.
International Journal of Molecular Sciences|November 4, 2020
Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer CellsLaura R Moffitt, Maree Bilandzic, Amy L Wilson, et al.
Fertility and Sterility|October 10, 2012
Proteomics of the human endometrium and uterine fluid: a pathway to biomarker discoveryLois A Salamonsen, Tracey Edgell, Luk J F Rombauts, et al.
Cell Reports|November 14, 2024
Leader cells promote immunosuppression to drive ovarian cancer progression in vivoAmy L Wilson, Laura R Moffitt, Brittany R Doran, et al.
Cancers|November 14, 2023
A Novel Predictive Multi-Marker Test for the Pre-Surgical Identification of Ovarian CancerAndrew N Stephens, Simon J Hobbs, Sung-Woon Kang, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2017
Autoantibodies against HSF1 and CCDC155 as Biomarkers of Early-Stage, High-Grade Serous Ovarian CancerAmy L Wilson, Laura R Moffitt, Nadine Duffield, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 2, 2021
Chemoresistance is mediated by ovarian cancer leader cells in vitroNazanin Karimnia, Amy L Wilson, Emma Green, et al.
Journal of Proteome Research|September 22, 2009
Proteomic identification of caldesmon as a physiological substrate of proprotein convertase 6 in human uterine decidual cells essential for pregnancy establishmentLynette M Kilpatrick, Andrew N Stephens, Belinda M Hardman, et al.
Frontiers in Oncology|October 26, 2020
Ovarian Blood Sampling Identifies Junction Plakoglobin as a Novel Biomarker of Early Ovarian CancerFlorian Weiland, Noor A Lokman, Manuela Klingler-Hoffmann, et al.
Cancers|August 27, 2021
Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This MalignancyRhiane Moody, Kirsty Wilson, Nirmala Chandralega Kampan, et al.
Plos One|August 4, 2012
Proteomic changes in rat spermatogenesis in response to in vivo androgen manipulation; impact on meiotic cellsPeter G Stanton, Pavel Sluka, Caroline F H Foo, et al.
International Journal of Molecular Sciences|November 4, 2020
Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer CellsLaura R Moffitt, Maree Bilandzic, Amy L Wilson, et al.
Fertility and Sterility|October 10, 2012
Proteomics of the human endometrium and uterine fluid: a pathway to biomarker discoveryLois A Salamonsen, Tracey Edgell, Luk J F Rombauts, et al.
Cell Reports|November 14, 2024
Leader cells promote immunosuppression to drive ovarian cancer progression in vivoAmy L Wilson, Laura R Moffitt, Brittany R Doran, et al.
Cancers|November 14, 2023
A Novel Predictive Multi-Marker Test for the Pre-Surgical Identification of Ovarian CancerAndrew N Stephens, Simon J Hobbs, Sung-Woon Kang, et al.
Pageof 7